• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.52% Nasdaq Down0.25%

    More On IBT.V



    News & Info


    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates


    • Major Holders
    • Insider Transactions
    • Insider Roster


    IBEX Technologies, Inc. (IBT.V)

    0.06 0.00(0.00%) Jul 30
    Add to Portfolio
    ProfileGet Profile for:
    IBEX Technologies, Inc.
    5485 Pare Street
    Suite 100
    Montreal, QC H4P 1P7
    Canada - Map
    Phone: 514-344-4004
    Fax: 514-344-8827
    Website: http://www.ibex.ca

    Index Membership:N/A
    Full Time Employees:N/A

    Business Summary 

    IBEX Technologies Inc., through its subsidiaries, manufactures and markets proteins for biomedical use. The company produces a portfolio of recombinant glycosaminoglycan lyases, including Heparinase I, Heparinase II, Heparinase III, Chondroitinase AC, and Chondroitinase B. It also manufactures and markets a series of arthritis assays, which are used in osteoarthritis research; a series of arthritis biomarkers; and diagnostic products. The company sells its products in Canada, the United States, Europe, and Other countries. IBEX Technologies Inc. is based in Montreal, Canada.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on IBEX Technologies, Inc.

    Key Executives 
    Mr. Paul Baehr , 72
    Chairman, Chief Exec. Officer and Pres
    Mr. Richard Collin CPA-CA,
    Director of Fin.
    Dr. Thomas O. Hecht Ph.D., M.D., 64
    Independent Director, Chairman of Compensation Committee, Member of Audit Committee, Member of Corp. Governance Committee and Pres of Haemosan Inc
    Mr. Claire Bergeron ,
    VP of Admin.
    Mr. Chee-Wui Chu ,
    VP of Research
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in CAD.